Current population · 2,231
Investing in the future of phage therapy.
Iredell J, Sacher J.
← ExplorerSource ↗Publication identity
Publication IDCPD-1905
Year2023
PMID41489883
DOINot recorded
JournalNot recorded
AuthorsIredell J, Sacher J.
First authorIredell J
Senior authorSacher J.
Scientific classification
Research themeAntimicrobial resistance; Phage therapy; Clinical infectious diseases
Pathogen groupNot specified / mixed
Technology / methodCulture / phenotypic methods; Clinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceIredell J
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/41489883/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →